Abstract
Mpox, formerly known as monkeypox, has shifted from a regional concern to a global health priority. Progress toward targeted antivirals and vaccines, however, still hinges on a complex array of animal models developed over the last sixty years. This review distills all literature regarding Mpox animal models–from rodent to non-human primate species–into a clear, comparative narrative. We outline how host species, viral clade, and inoculation route shape clinical course and immune responses, and we identify which models best address questions of pathogenesis, transmission, and medical countermeasure efficacy. The resulting roadmap is designed to help researchers, funders, and regulators select the most informative tools and streamline mpox drug discovery pipelines.
| Original language | English (US) |
|---|---|
| Article number | 2572676 |
| Pages (from-to) | 2572676 |
| Journal | Emerging Microbes and Infections |
| Volume | 15 |
| Issue number | 1 |
| DOIs | |
| State | Published - 2026 |
Keywords
- Animal model
- medical countermeasures
- monkeypox virus
- mpox
- pathogenesis
- therapeutics
- transmission
- vaccines
- Humans
- Mpox, Monkeypox/drug therapy
- Rodentia
- Monkeypox virus/drug effects
- Drug Discovery
- Animals
- Antiviral Agents/therapeutic use
- Primates
- Disease Models, Animal
ASJC Scopus subject areas
- Parasitology
- Epidemiology
- Microbiology
- Immunology
- Drug Discovery
- Virology
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Mpox animal models: a comprehensive evaluation of susceptible species for pathogenesis studies and drug discovery'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS